PMID: 8614292Jan 1, 1996Paper

N-docosahexaenoyl, 3 hydroxytyramine: a dopaminergic compound that penetrates the blood-brain barrier and suppresses appetite

Life Sciences
V E Shashoua, G W Hesse

Abstract

Fatty acids with varying chain lengths (2-22 carbon atoms long) and degrees of unsaturation (0-6 double bonds) were used to synthesize dopaminergic compounds for a study of the carrier mediated transport of dopamine (DA) to the brain. The most active carrier was the all cis C22:6 fatty acid [docosahexaenoic acid, (DHA)]which increased DA uptake through the blood-brain barrier by greater than 7.5 fold. The DHA-DA compound, NMI 8739, depressed the general locomotor activity of mice in a dose dependent manner. It also suppressed the appetite of Balb c mice and Charles River rats by 50% and 95% respectively at a dose of 10 mg/kg. Daily administration of NMI-8739 for a three week period did not induce tolerance. These results demonstrate DHA's potential for the carrier mediated transport of small molecules to the brain.

Citations

Jun 1, 1997·Journal of Clinical Pharmacology·M WeiserM A Abdeen
Apr 7, 2007·Bulletin of Experimental Biology and Medicine·M Yu BobrovV V Bezuglov
Jun 1, 2005·Chemistry and Physics of Lipids·Iwona MatuszewskaZbigniew Czarnocki
Mar 11, 1998·Peptides·S YehudaD I Mostofsky
Aug 26, 2000·Current Opinion in Chemical Biology·L H Van der Ploeg
May 11, 1999·Pharmaceutical Science & Technology Today·W M Pardridge
Jan 18, 2003·Vascular Pharmacology·J M Scherrmann
Aug 17, 2006·Nutritional Neuroscience·Sam J Bhathena
Jul 1, 1997·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·W M Pardridge
Apr 4, 2002·Drugs·José-Antonio Fernández-LópezMarià Alemany
Dec 1, 2001·Expert Opinion on Biological Therapy·J TemsamaniJ M Scherrmann
Jan 13, 2015·Transplantation Reviews·Johannes WedelBenito A Yard
Jun 23, 2012·International Journal of Pharmaceutics·Daniela AllhennAlf Lamprecht
Apr 14, 2015·BioMed Research International·Arijit BhowmikMrinal Kanti Ghosh
May 2, 2014·The Journal of Pharmacy and Pharmacology·Muhammad AdnanZabta Khan Shinwari
May 26, 2017·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Rami Walid ChakrounHonggang Cui
Dec 11, 2007·Neuroscience Letters·Mikhail Yu BobrovVladimir V Bezuglov
Aug 2, 2019·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Iu A SukhanovaN G Levitskaya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Related Papers

Doklady Biological Sciences : Proceedings of the Academy of Sciences of the USSR, Biological Sciences Sections
N Yu SakharovaV V Bezuglov
La Presse médicale
Didier QuilliotOlivier Ziegler
Proceedings of the Society for Experimental Biology and Medicine
C R BarbT F Mowles
© 2021 Meta ULC. All rights reserved